Omda ASOSL:OMDA +2.89%65 EBITDA Margin % is -3.86% as of Mar. 2026. GuruFocus rates OSL:OMDA with a GF Score™ of 65/100 and a GF Value™ of kr45.61 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Omda AS ranks better than 78.14% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Omda AS's EBITDA for the
three
months ended in Mar. 2026 was kr-4.6 Mil. Omda AS's Revenue for the
three
months ended in Mar. 2026 was kr119.3 Mil. Therefore, Omda AS's EBITDA margin for the quarter that ended in Mar. 2026 was -3.86%.
Omda AS (OSL:OMDA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Omda AS EBITDA Margin % Related Terms
Omda AS EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Omda AS's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:OMDA vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Omda AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omda AS EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Omda AS's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Omda AS's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omda AS (OSL:OMDA) has a EBITDA Margin % of -3.86% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Omda AS and its competitors. According to the industry distribution chart, Omda AS ranks #146 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 21.9%.
Is Omda AS's EBITDA Margin % too high?
Omda AS's current EBITDA Margin % is -3.86%. Based on the distribution chart, Omda AS ranks #146 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Omda AS has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Omda AS's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Omda AS ranks #146 out of 668 companies for EBITDA Margin %. This places Omda AS in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Omda AS and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omda AS's current EBITDA Margin % is -3.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omda AS stock overvalued right now?
Based on GuruFocus' analysis, Omda AS (OSL:OMDA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr45.61, compared to a current price of kr39.10 — trading 14.3% below its estimated fair value. The current EBITDA Margin % is -3.86%. Omda AS's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Omda AS (OSL:OMDA), the current EBITDA Margin % is -3.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omda AS (OSL:OMDA) Overvalued in 2026?
Based on GuruFocus' analysis, Omda AS stock appears to be undervalued.
The current stock price of kr39.10 is trading 14.3% below its estimated GF Value™ of kr45.61.
GuruFocus considers Omda AS to be Modestly Undervalued.
Key valuation signals for OSL:OMDA:
EBITDA Margin %: -3.86%
GF Value™: kr45.61 vs. price of kr39.10 (14.3% below fair value)
No single metric tells the full story. See the OSL:OMDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omda AS has built software tools exclusively for health and emergency professionals. Its Integration Engine and APIs enable its products to successfully merge with existing systems of all types and specifications. The company provides solutions in domains such as Emergency, Connected Imaging, Laboratory Information Management Systems, Medication Management, Health Analytics, and Women & Child. Geographically, the company generates the majority of its revenue from Norway, while it also has its presence in Sweden, Denmark, Finland, and Rest of the world.
65GF Score
Get the complete analysis for OSL:OMDA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:OMDA has been successfully added to your 
